BEAM Q2 2022 Earnings — Beam Therapeutics Inc. Revenue & Financial Results | Market Cap Arena

BEAMBeam Therapeutics Inc.

$3B

Q2 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$17M+277433.3% YoY

Gross Profit

-$58M-347.7% margin

Operating Income

-$82M-492.2% margin

Net Income

-$72M-432.1% margin

EPS (Diluted)

$-0.69

QoQ Revenue Growth

+97.5%

Cash Flow

Operating Cash Flow

-$52M

Free Cash Flow

-$74M

Stock-Based Comp.

$22M

Balance Sheet

Total Assets

$1.4B

Total Liabilities

$618M

Stockholders' Equity

$800M

Cash & Equivalents

$266M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$17M	$6,000	+277433.3%
Gross Profit	-$58M	-$46M	-27.1%
Operating Income	-$82M	-$59M	-39.0%
Net Income	-$72M	-$76M	+5.6%